Viewing Study NCT06466395


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-01-22 @ 7:42 AM
Study NCT ID: NCT06466395
Status: RECRUITING
Last Update Posted: 2025-09-08
First Post: 2024-06-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Acute Leukemia View
None Relapsed Acute Leukemia View
None Undifferentiated Leukemia View
None Bi-Phenotypic Leukemia View
Keywords: